Platinum Investment Management LTD Incyte Corp Transaction History

Platinum Investment Management LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$72.82 - $86.52 $1.75 Million - $2.08 Million	-24,033 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$73.52 - $88.7 $343,558 - $414,495	-4,673 Reduced 16.28%	24,033 $2.04 Million
Q4 2018 Feb 14, 2019	BUY	$58.5 - $69.94 $452,907 - $541,475	7,742 Added 36.93%	28,706 $1.83 Million
Q2 2018 Aug 15, 2018	BUY	$60.85 - $83.98 $687,605 - $948,974	11,300 Added 116.93%	20,964 $1.41 Million
Q1 2018 May 15, 2018	SELL	$83.06 - $100.98 $315,628 - $383,724	-3,800 Reduced 28.22%	9,664 $805,000

Q2 2017 Aug 15, 2017	BUY	N/A	13,464	13,464 $1.7 Million

617

215M

366K

445K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $13.1B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Platinum Investment Management LTD, based on Form 13F filings with the SEC.

Stay updated on Platinum Investment Management LTD with notifications on news.